Treacle Inhibitors
Treacle inhibitors as a class would refer to a group of compounds that interfere with the normal function of the Treacle protein or the expression of the TCOF1 gene. Since Treacle plays a role in ribosomal DNA gene transcription, and is critical in craniofacial development, inhibitors could work by interfering with the transcription machinery or affecting the post-transcriptional modification of ribosomal RNA. Some chemicals achieve this by inhibiting enzymes that modify chromatin structure, thus affecting gene expression globally, which would include genes like TCOF1.
Moreover, since Treacle is associated with cellular structures and the synthesis of ribosomes, inhibitors could target pathways involved in cell proliferation and ribosome biogenesis. For instance, compounds that hinder RNA polymerase II would disrupt the synthesis of mRNA, affecting the production of proteins required for ribosome assembly and function. Similarly, any disruption in the signaling pathways that control cell cycle progression and DNA damage response could lead to a reduction in Treacle protein levels or activity. These inhibitors, while not directly binding to the Treacle protein, exert their effect by altering the cellular context in which Treacle functions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits GSK-3β, which is involved in many cellular functions, including those that could intersect with Treacle's role in ribosomal DNA gene transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR, a kinase involved in cell growth and proliferation, potentially affecting the cell cycle and processes in which Treacle is involved. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, affecting DNA methylation and gene expression, which may indirectly influence the expression of genes such as TCOF1. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
An inhibitor of MEK, which is part of the MAPK/ERK pathway, and could affect cellular differentiation processes related to Treacle function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, impacting downstream AKT signaling, which can influence cell survival and protein synthesis processes involving Treacle. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
Inhibits p38 MAP kinase, affecting cellular responses to stress and inflammatory cytokines, possibly intersecting with Treacle's functional pathways. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, which may modify the cellular response to stress and apoptosis, potentially influencing the environment in which Treacle operates. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Disrupts the structure of eukaryotic translation initiation factor 4E (eIF4E), potentially affecting the translation of proteins including those related to Treacle's function in ribosome biogenesis. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
A diterpene triepoxide that can interfere with various transcription factors and inhibit RNA polymerase II activity, potentially reducing the expression of TCOF1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
A SERCA pump inhibitor that leads to the depletion of ER calcium stores, affecting calcium signaling which could intersect with signaling pathways involved in Treacle's function. | ||||||